Arcus Biosciences
RCUS
RCUS
193 hedge funds and large institutions have $791M invested in Arcus Biosciences in 2024 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 62 increasing their positions, 63 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2% less repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 63
1.07% less ownership
Funds ownership: 58.16% → 57.1% (-1.1%)
21% less capital invested
Capital invested by funds: $997M → $791M (-$207M)
Holders
193
Holding in Top 10
2
Calls
$3.58M
Puts
$2.31M
Top Buyers
| 1 | +$22M | |
| 2 | +$7.52M | |
| 3 | +$6.24M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$4.41M |
| 5 |
TI
Trexquant Investment
Stamford,
Connecticut
|
+$3.46M |
Top Sellers
| 1 | -$29.9M | |
| 2 | -$9.66M | |
| 3 | -$6.92M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$4.54M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$4.53M |